Is Balchem Corporation (BCPC) overvalued? · P/E 39, rev $240.0M
Balchem Corporation (BCPC) is a specialty chemicals company listed on US.
This page asks whether Balchem Corporation (BCPC) looks expensive on cached numbers — not a short thesis.
Latest reported BCPC revenue for 2024-12-31 was $240.0M. Net income was $33.6M. Revenue was up 0.0% from 2024-09-30 to 2024-12-31. BCPC currently screens at market cap $5.38B and trailing P/E 39.5.
BCPC currently screens at market cap $5.38B and trailing P/E 39.5. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.
If the next BCPC 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.
Not investment advice. Use the BCPC stock page for the full model, not this heading.
Not investment advice.